Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunovant Inc
(NQ:
IMVT
)
31.35
-0.37 (-1.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
618,185
Open
31.80
Bid (Size)
31.35 (31)
Ask (Size)
31.38 (2)
Prev. Close
31.72
Today's Range
31.07 - 31.83
52wk Range
19.94 - 45.58
Shares Outstanding
114,998,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
May 30, 2024
Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday.
Via
Investor's Business Daily
IMVT Stock Earnings: Immunovant Misses EPS for Q4 2024
May 29, 2024
IMVT stock results show that Immunovant missed analyst estimates for earnings per share the fourth quarter of 2024.
Via
InvestorPlace
Performance
YTD
-24.26%
-24.26%
1 Month
+7.77%
+7.77%
3 Month
+10.31%
+10.31%
6 Month
-18.27%
-18.27%
1 Year
+49.07%
+49.07%
More News
Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 29, 2024
Via
Benzinga
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
May 29, 2024
Via
Benzinga
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
Via
Benzinga
Recap: Immunovant Q3 Earnings
February 12, 2024
Via
Benzinga
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
May 29, 2024
Via
Benzinga
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
May 29, 2024
Via
Investor's Business Daily
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Via
InvestorPlace
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
March 21, 2024
Via
Investor's Business Daily
Argenx Dives On Autoimmune Therapy Failure
December 20, 2023
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
February 26, 2024
Via
InvestorPlace
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
February 06, 2024
Via
InvestorPlace
3 Top-Rated Russell 2000 Stocks Wall Street Analysts Are Loving Now: January 2024
January 19, 2024
Via
InvestorPlace
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
Via
The Motley Fool
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
December 22, 2023
Via
Investor's Business Daily
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Via
Benzinga
Immunovant Scores Much-Needed Win Following Argenx-Led Sell-off
December 21, 2023
Via
Investor's Business Daily
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
December 21, 2023
Via
Benzinga
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
December 21, 2023
Via
Benzinga
Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From
Roivant Sciences
Via
GlobeNewswire
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
Via
Benzinga
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.